TY - JOUR T1 - Role of the Prognostic Nutritional Index in Patients With Soft-tissue Sarcoma JF - In Vivo JO - In Vivo SP - 2349 LP - 2355 DO - 10.21873/invivo.12511 VL - 35 IS - 4 AU - YUMI MATSUYAMA AU - TOMOKI NAKAMURA AU - KEISUKE YOSHIDA AU - KOICHI NAKAMURA AU - TOMOHITO HAGI AU - KUNIHIRO ASANUMA AU - AKIHIRO SUDO Y1 - 2021/07/01 UR - http://iv.iiarjournals.org/content/35/4/2349.abstract N2 - Background: This study aimed to determine whether the prognostic nutritional index (PNI) can predict the prognosis in patients with soft-tissue sarcoma (STS) before treatment and to examine whether there is an association between PNI values and clinical characteristics. Patients and Methods: The data on 100 patients with primary STS were retrospectively reviewed. The cohort included 55 men and 45 women, with a mean age of 64 years. The mean follow-up duration was 41.7 months. Results: The median PNI was 51.35. The PNI was significantly inversely associated with tumor size, tumor grade, and age. We found that the PNI was a significant prognostic marker for disease-specific and event-free survival using univariate and multivariate analyses. Patients with a low PNI had poorer disease-specific and event-free survival than those with a high PNI. Conclusion: These results suggest that the PNI can be used as a prognostic marker in patients with STS. ER -